Show simple item record

Chapter 28 Genomics in emerging and developing economies

dc.contributor.authorGibbon, Sahra
dc.contributor.authorFullwiley, Duana
dc.date.accessioned2025-03-08T00:23:52Z
dc.date.available2025-03-08T00:23:52Z
dc.date.issued2018
dc.date.submitted2018-02-01 23:55:55
dc.date.submitted2019-10-18 14:02:57
dc.date.submitted2020-04-01T12:57:20Z
dc.identifier646139
dc.identifierOCN: 1030817571
dc.identifierhttp://library.oapen.org/handle/20.500.12657/30494
dc.identifier.urihttps://doab-dev.siscern.org/handle/20.500.12854/172635
dc.description.abstractLow and middle-income countries have become a site of increasing research interest and investment with the transnational expansion and spread of genomic knowledge and technologies (Kumar 2012, Seguin et al. 2008). This reflects a dynamic terrain in which genomics is being harnessed to address a range of healthcare challenges.
dc.languageEnglish
dc.rightsopen access
dc.subject.othergenomics
dc.subject.otherdeveloping economies
dc.subject.otherAfrica
dc.subject.otherBrazil
dc.subject.otherGenetics
dc.subject.otherHaplotype
dc.subject.otherPublic health
dc.subject.otherSenegal
dc.subject.otherSickle cell disease
dc.subject.otherthema EDItEUR::J Society and Social Sciences
dc.titleChapter 28 Genomics in emerging and developing economies
dc.typechapter
oapen.relation.isPublishedByfa69b019-f4ee-4979-8d42-c6b6c476b5f0
oapen.relation.isPartOfBookbefb36ff-d70d-4018-a062-f13ea4ee9f61
oapen.relation.isFundedByf6fcd900-36e2-4bc9-939e-ad820802e21f
oapen.relation.isbn9781315451695
oapen.collectionWellcome
oapen.imprintRoutledge
oapen.pages12
dc.relationisFundedByd859fbd3-d884-4090-a0ec-baf821c9abfd
dc.chapternumber28


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record